Company
ChinaNovacyl Wuxi Pharmaceutical Co., Ltd., Wuxi, China – FDA Inspections
Inspection records and compliance data for Novacyl Wuxi Pharmaceutical Co., Ltd. in Wuxi. 4 FDA inspections on record (2 OAI), 1 Form 483, 1 warning letter, last inspected September 15, 2017.
Company Profile
This profile covers Novacyl Wuxi Pharmaceutical Co., Ltd. based in Wuxi, China.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 2
- VAI
- 1
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 1
First inspected April 21, 2011. Last inspected September 15, 2017.
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 15, 2017 | Not classified | Human Drugs | 1029764 |
| April 14, 2016 | OAI | Human Drugs · Drug Quality Assurance | 965700 |
| October 18, 2013 | OAI | Human Drugs · Drug Quality Assurance | 853505 |
| April 21, 2011 | VAI | Human Drugs · Drug Quality Assurance | 735469 |
FDA documents
Warning Letters (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Novacyl Wuxi Pharmaceutical Co., Ltd.
FEI Number
3004117396
Address
8 Guangshi Road, Huishan, Wuxi, China
Country
China
ID: df90cc11-f2af-4bb7-bf70-f32a8bcc4fb8